Venture Partner

Nigel Sheail


Nigel Sheail is a venture partner based in Basel, Switzerland. He brings exceptional business development capabilities and deep insights into our industry from over two decades of leadership roles within the pharmaceutical sector. Nigel has been one of the pharma industry’s top dealmakers and his unique set of capabilities is intended to build on Versant’s track record of partnerships across the firm's portfolio.


Prior to joining Versant, Nigel was Global Head of Mergers & Acquisitions and Business Development & Licensing at Novartis, where he served as a member of the company’s senior leadership team. In that role, he was responsible for the execution of a broad range of healthcare deals spanning research and technology collaborations through to large M&A transactions. Prior to Novartis, Nigel was Head of Business Development and Licensing for Bayer Healthcare, and before that served as Head of Group M&A at Roche and Head of Licensing for its Pharma division.